Journal article icon

Journal article

Exploring Prior Antibiotic Exposure Characteristics for COVID-19 Hospital Admission Patients: OpenSAFELY

Abstract:
Previous studies have demonstrated the association between antibiotic use and severe COVID-19 outcomes. This study aimed to explore detailed antibiotic exposure characteristics among COVID-19 patients. Using the OpenSAFELY platform, which integrates extensive health data and covers 40% of the population in England, the study analysed 3.16 million COVID-19 patients with at least two prior antibiotic prescriptions. These patients were compared to up to six matched controls without hospitalisation records. A machine learning model categorised patients into ten groups based on their antibiotic exposure history over the three years before their COVID-19 diagnosis. The study found that for COVID-19 patients, the total number of prior antibiotic prescriptions, diversity of antibiotic types, broad-spectrum antibiotic prescriptions, time between first and last antibiotics, and recent antibiotic use were associated with an increased risk of severe COVID-19 outcomes. Patients in the highest decile of antibiotic exposure had an adjusted odds ratio of 4.8 for severe outcomes compared to those in the lowest decile. These findings suggest a potential link between extensive antibiotic use and the risk of severe COVID-19. This highlights the need for more judicious antibiotic prescribing in primary care, primarily for patients with higher risks of infection-related complications, which may better offset the potential adverse effects of repeated antibiotic use.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.3390/antibiotics13060566

Authors

More by this author
Role:
Author
ORCID:
0000-0001-5880-4827
More by this author
Role:
Author
ORCID:
0000-0001-8117-9193
More by this author
Role:
Author
ORCID:
0000-0002-3448-6702
More by this author
Role:
Author
ORCID:
0000-0002-1661-4475
More by this author
Role:
Author
ORCID:
0000-0002-2958-915X


More from this funder
Funder identifier:
https://ror.org/03x94j517
More from this funder
Funder identifier:
https://ror.org/00xm3h672
More from this funder
Funder identifier:
https://ror.org/0187kwz08


Publisher:
MDPI
Journal:
Antibiotics More from this journal
Volume:
13
Issue:
6
Article number:
566
Publication date:
2024-06-18
Acceptance date:
2024-06-11
DOI:
EISSN:
2079-6382
ISSN:
2079-6382


Language:
English
Keywords:
Pubs id:
2009681
Local pid:
pubs:2009681
Source identifiers:
2100287
Deposit date:
2024-07-10
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP